دورية أكاديمية
أعرض في EDS

Altered Levels of Sphingosine, Sphinganine and Their Ceramides in Atopic Dermatitis Are Related to Skin Barrier Function, Disease Severity and Local Cytokine Milieu.

التفاصيل البيبلوغرافية
العنوان: Altered Levels of Sphingosine, Sphinganine and Their Ceramides in Atopic Dermatitis Are Related to Skin Barrier Function, Disease Severity and Local Cytokine Milieu.
المؤلفون: Toncic RJ; Department of Dermatology and Venereology, University Hospital Center, Zagreb and University of Zagreb School of Medicine, 10000 Zagreb, Croatia., Jakasa I; Laboratory for Analytical Chemistry, Department of Chemistry and Biochemistry, Faculty of Food Technology and Biotechnology, University of Zagreb, 10000 Zagreb, Croatia.; Amsterdam UMC, University of Amsterdam, Coronel Institute of Occupational Health, Amsterdam Public Health research institute, 1105 AZ Amsterdam, The Netherlands., Hadzavdic SL; Department of Dermatology and Venereology, University Hospital Center, Zagreb and University of Zagreb School of Medicine, 10000 Zagreb, Croatia., Goorden SM; Laboratory Genetic Metabolic Disease, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands., Vlugt KJG; Laboratory Genetic Metabolic Disease, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands., Stet FS; Laboratory Genetic Metabolic Disease, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands., Balic A; Department of Dermatology and Venereology, University Hospital Center, Zagreb and University of Zagreb School of Medicine, 10000 Zagreb, Croatia., Petkovic M; Department of Dermatology and Venereology, University Hospital Center, Zagreb and University of Zagreb School of Medicine, 10000 Zagreb, Croatia., Pavicic B; Department of Dermatology and Venereology, University Hospital Center, Zagreb and University of Zagreb School of Medicine, 10000 Zagreb, Croatia., Zuzul K; Department of Dermatology and Venereology, University Hospital Center, Zagreb and University of Zagreb School of Medicine, 10000 Zagreb, Croatia., Marinovic B; Department of Dermatology and Venereology, University Hospital Center, Zagreb and University of Zagreb School of Medicine, 10000 Zagreb, Croatia., Kezic S; Amsterdam UMC, University of Amsterdam, Coronel Institute of Occupational Health, Amsterdam Public Health research institute, 1105 AZ Amsterdam, The Netherlands.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2020 Mar 13; Vol. 21 (6). Date of Electronic Publication: 2020 Mar 13.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2000-
مواضيع طبية MeSH: Ceramides/*metabolism , Cytokines/*metabolism , Dermatitis, Atopic/*metabolism , Sphingosine/*analogs & derivatives, Adult ; Biomarkers/metabolism ; Dermatitis, Atopic/pathology ; Female ; Humans ; Male ; Sphingosine/metabolism
مستخلص: Dysfunctional skin barrier plays a key role in the pathophysiology of atopic dermatitis (AD), a common inflammatory skin disease. Altered composition of ceramides is regarded as a major cause of skin barrier dysfunction, however it is not clear whether these changes are intrinsic or initiated by inflammation and aberrant immune response in AD. This study investigated the levels of free sphingoid bases (SBs) sphingosine and sphinganine and their ceramides and glucosylceramide in the stratum corneum (SC) and related them to skin barrier function, disease severity and local cytokine milieu. Ceramides were measured in healthy skin, and lesional and non-lesional skin of AD patients by a novel method based on deacylation of ceramides which were subsequently determined as corresponding sphingoid bases by using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The cytokine levels were determined by multiplex immunoassay. Atopic skin showed increased levels of most investigated markers, predominantly in lesional skin. The largest difference in respect to healthy skin was found for glucosylceramide with respective median values of 0.23 (IQR 0.18-0.61), 0.56 (IQR 0.32-0.76) and 19.32 (IQR 7.86-27.62) pmol/g protein for healthy, non-lesional and lesional skin. The levels of investigated ceramide markers were correlated with disease severity (scoring atopic dermatitis, SCORAD) and skin barrier function (trans-epidermal water loss, TEWL) and furthermore with cytokines involved in innate, Th-1, and Th-2 immune response. Interestingly, the strongest association with SCORAD was found for sphinganine/sphingosine ratio ( r = -0.69, p < 0.001; non-lesional skin), emphasizing the importance of SBs in AD. The highest correlation with TEWL was found for glucosylceramide ( r 2 = 0.60, p < 0.001), which was investigated for the first time in AD. Findings that the changes in SBs and ceramide levels were predominant in lesional skin and their association with disease severity and cytokine levels suggest an immune-system driven effect. a novel analysis method demonstrates a robust and simple approach that might facilitate wider use of lipid biomarkers in the clinics e.g., to monitor (immune) therapy or dissect disease endotypes.
References: J Invest Dermatol. 2010 Oct;130(10):2511-4. (PMID: 20574438)
Biochim Biophys Acta. 2014 Mar;1841(3):295-313. (PMID: 24252189)
Anal Bioanal Chem. 2016 Sep;408(24):6623-36. (PMID: 27473427)
Biochim Biophys Acta. 2014 Mar;1841(3):422-34. (PMID: 23988654)
Clin Chem. 2007 Apr;53(4):742-7. (PMID: 17332150)
J Dermatol Sci. 2020 Jan;97(1):2-8. (PMID: 31866207)
Curr Allergy Asthma Rep. 2009 Jul;9(4):265-72. (PMID: 19656472)
J Invest Dermatol. 1991 Apr;96(4):523-6. (PMID: 2007790)
J Invest Dermatol. 1983 Jun;80(1 Suppl):44s-9s. (PMID: 20479733)
JCI Insight. 2018 Feb 22;3(4):. (PMID: 29467325)
Cytokine. 2010 May;50(2):181-5. (PMID: 20236835)
Biochim Biophys Acta. 2014 Jan;1841(1):70-9. (PMID: 24120918)
Biochim Biophys Acta. 2016 Nov;1861(11):1652-1661. (PMID: 27422369)
J Dermatol Sci. 2017 Oct;88(1):57-66. (PMID: 28571749)
Adv Exp Med Biol. 1997;407:421-31. (PMID: 9321986)
Clin Chem. 2013 Mar;59(3):547-56. (PMID: 23237761)
J Lipid Res. 2008 Jul;49(7):1466-76. (PMID: 18359959)
Pediatr Allergy Immunol. 2016 Feb;27(1):99-102. (PMID: 26388323)
J Clin Invest. 2009 Jan;119(1):47-60. (PMID: 19075398)
Ann Allergy Asthma Immunol. 2018 Jan;120(1):34-41. (PMID: 29126710)
Biochimie. 2017 Oct;141:91-96. (PMID: 28341550)
Skin Pharmacol Physiol. 2013;26(1):36-44. (PMID: 23128426)
J Allergy Clin Immunol. 2018 Jun;141(6):2094-2106. (PMID: 29731129)
J Allergy Clin Immunol. 2008 Jun;121(6):1337-43. (PMID: 18329087)
J Am Acad Dermatol. 2014 Jul;71(1):177-84. (PMID: 24656726)
J Lipid Res. 2011 Jun;52(6):1211-21. (PMID: 21444759)
J Allergy Clin Immunol. 2009 Dec;124(6):1235-1244.e58. (PMID: 20004782)
J Lipid Res. 2012 Dec;53(12):2755-66. (PMID: 23024286)
J Allergy Clin Immunol. 2019 Jan;143(1):155-172. (PMID: 30194992)
Br J Dermatol. 2019 Mar;180(3):586-596. (PMID: 30132823)
Metabolomics. 2018 May 9;14(5):69. (PMID: 30830395)
J Am Acad Dermatol. 2019 Aug;81(2):510-519. (PMID: 31009665)
J Allergy Clin Immunol. 2019 Jan;143(1):26-35. (PMID: 30476499)
J Immunol Res. 2019 Jan 29;2019:3030268. (PMID: 30838224)
Dermatology. 1997;195(1):10-9. (PMID: 9267730)
Ann Allergy Asthma Immunol. 2017 Nov;119(5):446-451. (PMID: 28866311)
Curr Allergy Asthma Rep. 2008 Jul;8(4):299-305. (PMID: 18606081)
Exp Dermatol. 2014 Jan;23(1):45-52. (PMID: 24299153)
J Dermatol Sci. 2013 Dec;72(3):296-303. (PMID: 24070864)
J Invest Dermatol. 2014 Mar;134(3):712-718. (PMID: 24008422)
J Invest Dermatol. 2002 Aug;119(2):433-9. (PMID: 12190867)
Skin Res Technol. 2019 Jan;25(1):3-11. (PMID: 30030941)
Dermatitis. 2018 Jul/Aug;29(4):219-222. (PMID: 29939855)
Crit Care. 2002 Aug;6(4):335-41. (PMID: 12225610)
J Invest Dermatol. 2014 Jul;134(7):1941-1950. (PMID: 24518171)
Curr Probl Dermatol. 2016;49:8-26. (PMID: 26844894)
J Dermatol Sci. 2012 Oct;68(1):25-35. (PMID: 22884781)
Prog Lipid Res. 2016 Jul;63:50-69. (PMID: 27107674)
Nat Rev Dis Primers. 2018 Jun 21;4(1):1. (PMID: 29930242)
فهرسة مساهمة: Keywords: atopic dermatitis; biomarkers; ceramides; sphinganine; sphingosine; stratum corneum
المشرفين على المادة: 0 (Biomarkers)
0 (Ceramides)
0 (Cytokines)
NGZ37HRE42 (Sphingosine)
OWA98U788S (safingol)
تواريخ الأحداث: Date Created: 20200319 Date Completed: 20201201 Latest Revision: 20201201
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC7139865
DOI: 10.3390/ijms21061958
PMID: 32183011
قاعدة البيانات: MEDLINE
الوصف
تدمد:1422-0067
DOI:10.3390/ijms21061958